nodes	percent_of_prediction	percent_of_DWPC	metapath
Cevimeline—CYP2D6—Progesterone—uterine cancer	0.0904	0.296	CbGbCtD
Cevimeline—CYP3A4—Medroxyprogesterone Acetate—uterine cancer	0.0868	0.284	CbGbCtD
Cevimeline—CYP3A4—Progesterone—uterine cancer	0.0575	0.188	CbGbCtD
Cevimeline—CHRM3—ureter—uterine cancer	0.0368	0.278	CbGeAlD
Cevimeline—CYP2D6—Doxorubicin—uterine cancer	0.0276	0.0903	CbGbCtD
Cevimeline—CHRM3—muscle of abdomen—uterine cancer	0.0265	0.2	CbGeAlD
Cevimeline—CYP3A4—Etoposide—uterine cancer	0.0257	0.0842	CbGbCtD
Cevimeline—CYP3A4—Doxorubicin—uterine cancer	0.0175	0.0574	CbGbCtD
Cevimeline—FMO1—uterine cervix—uterine cancer	0.00761	0.0575	CbGeAlD
Cevimeline—CHRM3—exocrine gland—uterine cancer	0.00725	0.0547	CbGeAlD
Cevimeline—FMO1—renal system—uterine cancer	0.00712	0.0538	CbGeAlD
Cevimeline—FMO1—endometrium—uterine cancer	0.00688	0.052	CbGeAlD
Cevimeline—FMO1—mammalian vulva—uterine cancer	0.00666	0.0503	CbGeAlD
Cevimeline—FMO1—female gonad—uterine cancer	0.00519	0.0392	CbGeAlD
Cevimeline—FMO1—vagina—uterine cancer	0.00516	0.0389	CbGeAlD
Cevimeline—FMO1—lymph node—uterine cancer	0.00333	0.0252	CbGeAlD
Cevimeline—CHRM3—smooth muscle tissue—uterine cancer	0.00304	0.0229	CbGeAlD
Cevimeline—CHRM3—renal system—uterine cancer	0.00292	0.0221	CbGeAlD
Cevimeline—CHRM1—female reproductive system—uterine cancer	0.00262	0.0198	CbGeAlD
Cevimeline—CHRM3—female reproductive system—uterine cancer	0.00234	0.0177	CbGeAlD
Cevimeline—CHRM3—female gonad—uterine cancer	0.00213	0.0161	CbGeAlD
Cevimeline—CYP3A4—renal system—uterine cancer	0.00161	0.0121	CbGeAlD
Cevimeline—CYP2D6—renal system—uterine cancer	0.00158	0.0119	CbGeAlD
Cevimeline—CYP3A4—female reproductive system—uterine cancer	0.00129	0.00972	CbGeAlD
Cevimeline—CYP2D6—female reproductive system—uterine cancer	0.00127	0.00957	CbGeAlD
Cevimeline—CYP2D6—female gonad—uterine cancer	0.00115	0.0087	CbGeAlD
Cevimeline—Gastrointestinal haemorrhage—Doxorubicin—uterine cancer	0.000267	0.000475	CcSEcCtD
Cevimeline—Diplopia—Doxorubicin—uterine cancer	0.000267	0.000475	CcSEcCtD
Cevimeline—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.000266	0.000474	CcSEcCtD
Cevimeline—Dry skin—Epirubicin—uterine cancer	0.000265	0.000471	CcSEcCtD
Cevimeline—Chest pain—Etoposide—uterine cancer	0.000264	0.00047	CcSEcCtD
Cevimeline—Orthostatic hypotension—Epirubicin—uterine cancer	0.000264	0.000469	CcSEcCtD
Cevimeline—Affect lability—Doxorubicin—uterine cancer	0.000263	0.000468	CcSEcCtD
Cevimeline—Migraine—Doxorubicin—uterine cancer	0.000263	0.000468	CcSEcCtD
Cevimeline—Hypokalaemia—Epirubicin—uterine cancer	0.000263	0.000468	CcSEcCtD
Cevimeline—Discomfort—Etoposide—uterine cancer	0.000261	0.000464	CcSEcCtD
Cevimeline—Face oedema—Doxorubicin—uterine cancer	0.000258	0.000459	CcSEcCtD
Cevimeline—Hypersensitivity—Dactinomycin—uterine cancer	0.000258	0.000459	CcSEcCtD
Cevimeline—Gastritis—Epirubicin—uterine cancer	0.000256	0.000455	CcSEcCtD
Cevimeline—Confusional state—Etoposide—uterine cancer	0.000255	0.000454	CcSEcCtD
Cevimeline—Muscular weakness—Epirubicin—uterine cancer	0.000255	0.000453	CcSEcCtD
Cevimeline—Alanine aminotransferase increased—Epirubicin—uterine cancer	0.000255	0.000453	CcSEcCtD
Cevimeline—Mood swings—Doxorubicin—uterine cancer	0.000253	0.00045	CcSEcCtD
Cevimeline—Infection—Etoposide—uterine cancer	0.000252	0.000448	CcSEcCtD
Cevimeline—Abdominal distension—Epirubicin—uterine cancer	0.000251	0.000447	CcSEcCtD
Cevimeline—Asthenia—Dactinomycin—uterine cancer	0.000251	0.000447	CcSEcCtD
Cevimeline—Asthma—Epirubicin—uterine cancer	0.00025	0.000444	CcSEcCtD
Cevimeline—Dysphagia—Epirubicin—uterine cancer	0.00025	0.000444	CcSEcCtD
Cevimeline—Dehydration—Doxorubicin—uterine cancer	0.000248	0.000442	CcSEcCtD
Cevimeline—Thrombocytopenia—Etoposide—uterine cancer	0.000248	0.000441	CcSEcCtD
Cevimeline—Tachycardia—Etoposide—uterine cancer	0.000247	0.00044	CcSEcCtD
Cevimeline—Eosinophilia—Epirubicin—uterine cancer	0.000247	0.00044	CcSEcCtD
Cevimeline—Skin disorder—Etoposide—uterine cancer	0.000246	0.000438	CcSEcCtD
Cevimeline—Dry skin—Doxorubicin—uterine cancer	0.000245	0.000436	CcSEcCtD
Cevimeline—Hyperhidrosis—Etoposide—uterine cancer	0.000245	0.000435	CcSEcCtD
Cevimeline—Orthostatic hypotension—Doxorubicin—uterine cancer	0.000244	0.000434	CcSEcCtD
Cevimeline—Hypokalaemia—Doxorubicin—uterine cancer	0.000243	0.000433	CcSEcCtD
Cevimeline—Angina pectoris—Epirubicin—uterine cancer	0.000243	0.000433	CcSEcCtD
Cevimeline—Anorexia—Etoposide—uterine cancer	0.000241	0.000429	CcSEcCtD
Cevimeline—Bronchitis—Epirubicin—uterine cancer	0.00024	0.000427	CcSEcCtD
Cevimeline—Diarrhoea—Dactinomycin—uterine cancer	0.000239	0.000426	CcSEcCtD
Cevimeline—Hypotension—Etoposide—uterine cancer	0.000237	0.000421	CcSEcCtD
Cevimeline—Gastritis—Doxorubicin—uterine cancer	0.000236	0.000421	CcSEcCtD
Cevimeline—Muscular weakness—Doxorubicin—uterine cancer	0.000236	0.000419	CcSEcCtD
Cevimeline—Alanine aminotransferase increased—Doxorubicin—uterine cancer	0.000236	0.000419	CcSEcCtD
Cevimeline—Dysuria—Epirubicin—uterine cancer	0.000233	0.000415	CcSEcCtD
Cevimeline—Abdominal distension—Doxorubicin—uterine cancer	0.000232	0.000414	CcSEcCtD
Cevimeline—Upper respiratory tract infection—Epirubicin—uterine cancer	0.000232	0.000413	CcSEcCtD
Cevimeline—Asthma—Doxorubicin—uterine cancer	0.000231	0.000411	CcSEcCtD
Cevimeline—Dysphagia—Doxorubicin—uterine cancer	0.000231	0.000411	CcSEcCtD
Cevimeline—Pollakiuria—Epirubicin—uterine cancer	0.000231	0.00041	CcSEcCtD
Cevimeline—Eosinophilia—Doxorubicin—uterine cancer	0.000229	0.000407	CcSEcCtD
Cevimeline—Photosensitivity reaction—Epirubicin—uterine cancer	0.000228	0.000405	CcSEcCtD
Cevimeline—Paraesthesia—Etoposide—uterine cancer	0.000227	0.000404	CcSEcCtD
Cevimeline—Weight increased—Epirubicin—uterine cancer	0.000227	0.000404	CcSEcCtD
Cevimeline—Weight decreased—Epirubicin—uterine cancer	0.000226	0.000402	CcSEcCtD
Cevimeline—Dyspnoea—Etoposide—uterine cancer	0.000226	0.000402	CcSEcCtD
Cevimeline—Hyperglycaemia—Epirubicin—uterine cancer	0.000225	0.000401	CcSEcCtD
Cevimeline—Somnolence—Etoposide—uterine cancer	0.000225	0.0004	CcSEcCtD
Cevimeline—Angina pectoris—Doxorubicin—uterine cancer	0.000225	0.0004	CcSEcCtD
Cevimeline—Pneumonia—Epirubicin—uterine cancer	0.000224	0.000398	CcSEcCtD
Cevimeline—Vomiting—Dactinomycin—uterine cancer	0.000222	0.000396	CcSEcCtD
Cevimeline—Bronchitis—Doxorubicin—uterine cancer	0.000222	0.000395	CcSEcCtD
Cevimeline—Rash—Dactinomycin—uterine cancer	0.000221	0.000392	CcSEcCtD
Cevimeline—Decreased appetite—Etoposide—uterine cancer	0.00022	0.000392	CcSEcCtD
Cevimeline—Fatigue—Etoposide—uterine cancer	0.000218	0.000388	CcSEcCtD
Cevimeline—Neuropathy peripheral—Epirubicin—uterine cancer	0.000218	0.000388	CcSEcCtD
Cevimeline—Stomatitis—Epirubicin—uterine cancer	0.000217	0.000386	CcSEcCtD
Cevimeline—Pain—Etoposide—uterine cancer	0.000216	0.000385	CcSEcCtD
Cevimeline—Constipation—Etoposide—uterine cancer	0.000216	0.000385	CcSEcCtD
Cevimeline—Conjunctivitis—Epirubicin—uterine cancer	0.000216	0.000385	CcSEcCtD
Cevimeline—Urinary tract infection—Epirubicin—uterine cancer	0.000216	0.000385	CcSEcCtD
Cevimeline—Dysuria—Doxorubicin—uterine cancer	0.000216	0.000384	CcSEcCtD
Cevimeline—Upper respiratory tract infection—Doxorubicin—uterine cancer	0.000215	0.000382	CcSEcCtD
Cevimeline—Pollakiuria—Doxorubicin—uterine cancer	0.000213	0.00038	CcSEcCtD
Cevimeline—Haematuria—Epirubicin—uterine cancer	0.000212	0.000377	CcSEcCtD
Cevimeline—Photosensitivity reaction—Doxorubicin—uterine cancer	0.000211	0.000375	CcSEcCtD
Cevimeline—Weight increased—Doxorubicin—uterine cancer	0.00021	0.000374	CcSEcCtD
Cevimeline—Epistaxis—Epirubicin—uterine cancer	0.00021	0.000373	CcSEcCtD
Cevimeline—Weight decreased—Doxorubicin—uterine cancer	0.000209	0.000372	CcSEcCtD
Cevimeline—Sinusitis—Epirubicin—uterine cancer	0.000209	0.000371	CcSEcCtD
Cevimeline—Feeling abnormal—Etoposide—uterine cancer	0.000209	0.000371	CcSEcCtD
Cevimeline—Hyperglycaemia—Doxorubicin—uterine cancer	0.000208	0.000371	CcSEcCtD
Cevimeline—Nausea—Dactinomycin—uterine cancer	0.000208	0.00037	CcSEcCtD
Cevimeline—Agranulocytosis—Epirubicin—uterine cancer	0.000208	0.000369	CcSEcCtD
Cevimeline—Pneumonia—Doxorubicin—uterine cancer	0.000207	0.000368	CcSEcCtD
Cevimeline—Gastrointestinal pain—Etoposide—uterine cancer	0.000207	0.000368	CcSEcCtD
Cevimeline—Neuropathy peripheral—Doxorubicin—uterine cancer	0.000202	0.000359	CcSEcCtD
Cevimeline—Urticaria—Etoposide—uterine cancer	0.000201	0.000358	CcSEcCtD
Cevimeline—Haemoglobin—Epirubicin—uterine cancer	0.000201	0.000357	CcSEcCtD
Cevimeline—Stomatitis—Doxorubicin—uterine cancer	0.000201	0.000357	CcSEcCtD
Cevimeline—Rhinitis—Epirubicin—uterine cancer	0.0002	0.000356	CcSEcCtD
Cevimeline—Body temperature increased—Etoposide—uterine cancer	0.0002	0.000356	CcSEcCtD
Cevimeline—Abdominal pain—Etoposide—uterine cancer	0.0002	0.000356	CcSEcCtD
Cevimeline—Conjunctivitis—Doxorubicin—uterine cancer	0.0002	0.000356	CcSEcCtD
Cevimeline—Urinary tract infection—Doxorubicin—uterine cancer	0.0002	0.000356	CcSEcCtD
Cevimeline—Haemorrhage—Epirubicin—uterine cancer	0.0002	0.000355	CcSEcCtD
Cevimeline—Hypoaesthesia—Epirubicin—uterine cancer	0.000199	0.000354	CcSEcCtD
Cevimeline—Pharyngitis—Epirubicin—uterine cancer	0.000198	0.000353	CcSEcCtD
Cevimeline—Oedema peripheral—Epirubicin—uterine cancer	0.000197	0.00035	CcSEcCtD
Cevimeline—Haematuria—Doxorubicin—uterine cancer	0.000196	0.000349	CcSEcCtD
Cevimeline—Urethral disorder—Epirubicin—uterine cancer	0.000196	0.000348	CcSEcCtD
Cevimeline—Epistaxis—Doxorubicin—uterine cancer	0.000194	0.000346	CcSEcCtD
Cevimeline—Sinusitis—Doxorubicin—uterine cancer	0.000193	0.000344	CcSEcCtD
Cevimeline—Visual impairment—Epirubicin—uterine cancer	0.000192	0.000343	CcSEcCtD
Cevimeline—Agranulocytosis—Doxorubicin—uterine cancer	0.000192	0.000342	CcSEcCtD
Cevimeline—Eye disorder—Epirubicin—uterine cancer	0.000187	0.000332	CcSEcCtD
Cevimeline—Hypersensitivity—Etoposide—uterine cancer	0.000187	0.000332	CcSEcCtD
Cevimeline—Tinnitus—Epirubicin—uterine cancer	0.000186	0.000331	CcSEcCtD
Cevimeline—Haemoglobin—Doxorubicin—uterine cancer	0.000186	0.000331	CcSEcCtD
Cevimeline—Flushing—Epirubicin—uterine cancer	0.000185	0.00033	CcSEcCtD
Cevimeline—Cardiac disorder—Epirubicin—uterine cancer	0.000185	0.00033	CcSEcCtD
Cevimeline—Rhinitis—Doxorubicin—uterine cancer	0.000185	0.00033	CcSEcCtD
Cevimeline—Haemorrhage—Doxorubicin—uterine cancer	0.000185	0.000329	CcSEcCtD
Cevimeline—Hypoaesthesia—Doxorubicin—uterine cancer	0.000184	0.000327	CcSEcCtD
Cevimeline—Pharyngitis—Doxorubicin—uterine cancer	0.000183	0.000326	CcSEcCtD
Cevimeline—Oedema peripheral—Doxorubicin—uterine cancer	0.000182	0.000324	CcSEcCtD
Cevimeline—Asthenia—Etoposide—uterine cancer	0.000182	0.000323	CcSEcCtD
Cevimeline—Angiopathy—Epirubicin—uterine cancer	0.000181	0.000322	CcSEcCtD
Cevimeline—Urethral disorder—Doxorubicin—uterine cancer	0.000181	0.000322	CcSEcCtD
Cevimeline—Chills—Epirubicin—uterine cancer	0.000179	0.000319	CcSEcCtD
Cevimeline—Pruritus—Etoposide—uterine cancer	0.000179	0.000319	CcSEcCtD
Cevimeline—Arrhythmia—Epirubicin—uterine cancer	0.000178	0.000318	CcSEcCtD
Cevimeline—Visual impairment—Doxorubicin—uterine cancer	0.000178	0.000317	CcSEcCtD
Cevimeline—Alopecia—Epirubicin—uterine cancer	0.000177	0.000314	CcSEcCtD
Cevimeline—Malnutrition—Epirubicin—uterine cancer	0.000174	0.000309	CcSEcCtD
Cevimeline—Diarrhoea—Etoposide—uterine cancer	0.000173	0.000308	CcSEcCtD
Cevimeline—Eye disorder—Doxorubicin—uterine cancer	0.000173	0.000307	CcSEcCtD
Cevimeline—Tinnitus—Doxorubicin—uterine cancer	0.000172	0.000307	CcSEcCtD
Cevimeline—Cardiac disorder—Doxorubicin—uterine cancer	0.000172	0.000305	CcSEcCtD
Cevimeline—Flushing—Doxorubicin—uterine cancer	0.000172	0.000305	CcSEcCtD
Cevimeline—Flatulence—Epirubicin—uterine cancer	0.000171	0.000305	CcSEcCtD
Cevimeline—Dysgeusia—Epirubicin—uterine cancer	0.00017	0.000303	CcSEcCtD
Cevimeline—Back pain—Epirubicin—uterine cancer	0.000168	0.000299	CcSEcCtD
Cevimeline—Angiopathy—Doxorubicin—uterine cancer	0.000168	0.000298	CcSEcCtD
Cevimeline—Dizziness—Etoposide—uterine cancer	0.000167	0.000298	CcSEcCtD
Cevimeline—Muscle spasms—Epirubicin—uterine cancer	0.000167	0.000297	CcSEcCtD
Cevimeline—Chills—Doxorubicin—uterine cancer	0.000166	0.000295	CcSEcCtD
Cevimeline—Arrhythmia—Doxorubicin—uterine cancer	0.000165	0.000294	CcSEcCtD
Cevimeline—Alopecia—Doxorubicin—uterine cancer	0.000163	0.000291	CcSEcCtD
Cevimeline—Ill-defined disorder—Epirubicin—uterine cancer	0.000161	0.000287	CcSEcCtD
Cevimeline—Vomiting—Etoposide—uterine cancer	0.000161	0.000286	CcSEcCtD
Cevimeline—Malnutrition—Doxorubicin—uterine cancer	0.000161	0.000286	CcSEcCtD
Cevimeline—Anaemia—Epirubicin—uterine cancer	0.000161	0.000286	CcSEcCtD
Cevimeline—Agitation—Epirubicin—uterine cancer	0.00016	0.000284	CcSEcCtD
Cevimeline—Rash—Etoposide—uterine cancer	0.00016	0.000284	CcSEcCtD
Cevimeline—Dermatitis—Etoposide—uterine cancer	0.000159	0.000284	CcSEcCtD
Cevimeline—Headache—Etoposide—uterine cancer	0.000159	0.000282	CcSEcCtD
Cevimeline—Flatulence—Doxorubicin—uterine cancer	0.000159	0.000282	CcSEcCtD
Cevimeline—Dysgeusia—Doxorubicin—uterine cancer	0.000158	0.00028	CcSEcCtD
Cevimeline—Malaise—Epirubicin—uterine cancer	0.000157	0.000279	CcSEcCtD
Cevimeline—Vertigo—Epirubicin—uterine cancer	0.000156	0.000278	CcSEcCtD
Cevimeline—Syncope—Epirubicin—uterine cancer	0.000156	0.000277	CcSEcCtD
Cevimeline—Leukopenia—Epirubicin—uterine cancer	0.000156	0.000277	CcSEcCtD
Cevimeline—Back pain—Doxorubicin—uterine cancer	0.000156	0.000277	CcSEcCtD
Cevimeline—Muscle spasms—Doxorubicin—uterine cancer	0.000155	0.000275	CcSEcCtD
Cevimeline—Palpitations—Epirubicin—uterine cancer	0.000154	0.000273	CcSEcCtD
Cevimeline—Loss of consciousness—Epirubicin—uterine cancer	0.000153	0.000272	CcSEcCtD
Cevimeline—Cough—Epirubicin—uterine cancer	0.000152	0.00027	CcSEcCtD
Cevimeline—Convulsion—Epirubicin—uterine cancer	0.000151	0.000268	CcSEcCtD
Cevimeline—Nausea—Etoposide—uterine cancer	0.00015	0.000268	CcSEcCtD
Cevimeline—Hypertension—Epirubicin—uterine cancer	0.00015	0.000267	CcSEcCtD
Cevimeline—Ill-defined disorder—Doxorubicin—uterine cancer	0.000149	0.000266	CcSEcCtD
Cevimeline—Anaemia—Doxorubicin—uterine cancer	0.000149	0.000265	CcSEcCtD
Cevimeline—Chest pain—Epirubicin—uterine cancer	0.000148	0.000263	CcSEcCtD
Cevimeline—Myalgia—Epirubicin—uterine cancer	0.000148	0.000263	CcSEcCtD
Cevimeline—Arthralgia—Epirubicin—uterine cancer	0.000148	0.000263	CcSEcCtD
Cevimeline—Agitation—Doxorubicin—uterine cancer	0.000148	0.000263	CcSEcCtD
Cevimeline—Anxiety—Epirubicin—uterine cancer	0.000148	0.000262	CcSEcCtD
Cevimeline—Discomfort—Epirubicin—uterine cancer	0.000146	0.00026	CcSEcCtD
Cevimeline—Malaise—Doxorubicin—uterine cancer	0.000145	0.000258	CcSEcCtD
Cevimeline—Vertigo—Doxorubicin—uterine cancer	0.000145	0.000257	CcSEcCtD
Cevimeline—Syncope—Doxorubicin—uterine cancer	0.000144	0.000257	CcSEcCtD
Cevimeline—Leukopenia—Doxorubicin—uterine cancer	0.000144	0.000256	CcSEcCtD
Cevimeline—Confusional state—Epirubicin—uterine cancer	0.000143	0.000255	CcSEcCtD
Cevimeline—Palpitations—Doxorubicin—uterine cancer	0.000142	0.000253	CcSEcCtD
Cevimeline—Oedema—Epirubicin—uterine cancer	0.000142	0.000253	CcSEcCtD
Cevimeline—Loss of consciousness—Doxorubicin—uterine cancer	0.000141	0.000252	CcSEcCtD
Cevimeline—Infection—Epirubicin—uterine cancer	0.000141	0.000251	CcSEcCtD
Cevimeline—Cough—Doxorubicin—uterine cancer	0.00014	0.00025	CcSEcCtD
Cevimeline—Shock—Epirubicin—uterine cancer	0.00014	0.000248	CcSEcCtD
Cevimeline—Convulsion—Doxorubicin—uterine cancer	0.000139	0.000248	CcSEcCtD
Cevimeline—Nervous system disorder—Epirubicin—uterine cancer	0.000139	0.000248	CcSEcCtD
Cevimeline—Thrombocytopenia—Epirubicin—uterine cancer	0.000139	0.000247	CcSEcCtD
Cevimeline—Hypertension—Doxorubicin—uterine cancer	0.000139	0.000247	CcSEcCtD
Cevimeline—Tachycardia—Epirubicin—uterine cancer	0.000139	0.000246	CcSEcCtD
Cevimeline—Skin disorder—Epirubicin—uterine cancer	0.000138	0.000245	CcSEcCtD
Cevimeline—Hyperhidrosis—Epirubicin—uterine cancer	0.000137	0.000244	CcSEcCtD
Cevimeline—Arthralgia—Doxorubicin—uterine cancer	0.000137	0.000244	CcSEcCtD
Cevimeline—Myalgia—Doxorubicin—uterine cancer	0.000137	0.000244	CcSEcCtD
Cevimeline—Chest pain—Doxorubicin—uterine cancer	0.000137	0.000244	CcSEcCtD
Cevimeline—Anxiety—Doxorubicin—uterine cancer	0.000136	0.000243	CcSEcCtD
Cevimeline—Discomfort—Doxorubicin—uterine cancer	0.000135	0.000241	CcSEcCtD
Cevimeline—Anorexia—Epirubicin—uterine cancer	0.000135	0.000241	CcSEcCtD
Cevimeline—Hypotension—Epirubicin—uterine cancer	0.000133	0.000236	CcSEcCtD
Cevimeline—Confusional state—Doxorubicin—uterine cancer	0.000132	0.000236	CcSEcCtD
Cevimeline—Oedema—Doxorubicin—uterine cancer	0.000131	0.000234	CcSEcCtD
Cevimeline—Infection—Doxorubicin—uterine cancer	0.00013	0.000232	CcSEcCtD
Cevimeline—Musculoskeletal discomfort—Epirubicin—uterine cancer	0.000129	0.00023	CcSEcCtD
Cevimeline—Shock—Doxorubicin—uterine cancer	0.000129	0.00023	CcSEcCtD
Cevimeline—Nervous system disorder—Doxorubicin—uterine cancer	0.000129	0.000229	CcSEcCtD
Cevimeline—Thrombocytopenia—Doxorubicin—uterine cancer	0.000129	0.000229	CcSEcCtD
Cevimeline—Insomnia—Epirubicin—uterine cancer	0.000128	0.000228	CcSEcCtD
Cevimeline—Tachycardia—Doxorubicin—uterine cancer	0.000128	0.000228	CcSEcCtD
Cevimeline—Skin disorder—Doxorubicin—uterine cancer	0.000128	0.000227	CcSEcCtD
Cevimeline—Paraesthesia—Epirubicin—uterine cancer	0.000127	0.000227	CcSEcCtD
Cevimeline—Hyperhidrosis—Doxorubicin—uterine cancer	0.000127	0.000226	CcSEcCtD
Cevimeline—Dyspnoea—Epirubicin—uterine cancer	0.000127	0.000225	CcSEcCtD
Cevimeline—Somnolence—Epirubicin—uterine cancer	0.000126	0.000224	CcSEcCtD
Cevimeline—Anorexia—Doxorubicin—uterine cancer	0.000125	0.000223	CcSEcCtD
Cevimeline—Dyspepsia—Epirubicin—uterine cancer	0.000125	0.000222	CcSEcCtD
Cevimeline—Decreased appetite—Epirubicin—uterine cancer	0.000123	0.00022	CcSEcCtD
Cevimeline—Hypotension—Doxorubicin—uterine cancer	0.000123	0.000218	CcSEcCtD
Cevimeline—Fatigue—Epirubicin—uterine cancer	0.000122	0.000218	CcSEcCtD
Cevimeline—Constipation—Epirubicin—uterine cancer	0.000121	0.000216	CcSEcCtD
Cevimeline—Pain—Epirubicin—uterine cancer	0.000121	0.000216	CcSEcCtD
Cevimeline—Musculoskeletal discomfort—Doxorubicin—uterine cancer	0.00012	0.000213	CcSEcCtD
Cevimeline—Insomnia—Doxorubicin—uterine cancer	0.000119	0.000211	CcSEcCtD
Cevimeline—Paraesthesia—Doxorubicin—uterine cancer	0.000118	0.00021	CcSEcCtD
Cevimeline—Dyspnoea—Doxorubicin—uterine cancer	0.000117	0.000208	CcSEcCtD
Cevimeline—Feeling abnormal—Epirubicin—uterine cancer	0.000117	0.000208	CcSEcCtD
Cevimeline—Somnolence—Doxorubicin—uterine cancer	0.000117	0.000208	CcSEcCtD
Cevimeline—Gastrointestinal pain—Epirubicin—uterine cancer	0.000116	0.000206	CcSEcCtD
Cevimeline—Dyspepsia—Doxorubicin—uterine cancer	0.000116	0.000206	CcSEcCtD
Cevimeline—Decreased appetite—Doxorubicin—uterine cancer	0.000114	0.000203	CcSEcCtD
Cevimeline—Fatigue—Doxorubicin—uterine cancer	0.000113	0.000201	CcSEcCtD
Cevimeline—Urticaria—Epirubicin—uterine cancer	0.000113	0.000201	CcSEcCtD
Cevimeline—Pain—Doxorubicin—uterine cancer	0.000112	0.0002	CcSEcCtD
Cevimeline—Constipation—Doxorubicin—uterine cancer	0.000112	0.0002	CcSEcCtD
Cevimeline—Abdominal pain—Epirubicin—uterine cancer	0.000112	0.0002	CcSEcCtD
Cevimeline—Body temperature increased—Epirubicin—uterine cancer	0.000112	0.0002	CcSEcCtD
Cevimeline—Feeling abnormal—Doxorubicin—uterine cancer	0.000108	0.000193	CcSEcCtD
Cevimeline—Gastrointestinal pain—Doxorubicin—uterine cancer	0.000107	0.000191	CcSEcCtD
Cevimeline—Hypersensitivity—Epirubicin—uterine cancer	0.000105	0.000186	CcSEcCtD
Cevimeline—Urticaria—Doxorubicin—uterine cancer	0.000104	0.000186	CcSEcCtD
Cevimeline—Abdominal pain—Doxorubicin—uterine cancer	0.000104	0.000185	CcSEcCtD
Cevimeline—Body temperature increased—Doxorubicin—uterine cancer	0.000104	0.000185	CcSEcCtD
Cevimeline—Asthenia—Epirubicin—uterine cancer	0.000102	0.000181	CcSEcCtD
Cevimeline—Pruritus—Epirubicin—uterine cancer	0.0001	0.000179	CcSEcCtD
Cevimeline—Diarrhoea—Epirubicin—uterine cancer	9.71e-05	0.000173	CcSEcCtD
Cevimeline—Hypersensitivity—Doxorubicin—uterine cancer	9.67e-05	0.000172	CcSEcCtD
Cevimeline—Asthenia—Doxorubicin—uterine cancer	9.42e-05	0.000168	CcSEcCtD
Cevimeline—Dizziness—Epirubicin—uterine cancer	9.38e-05	0.000167	CcSEcCtD
Cevimeline—Pruritus—Doxorubicin—uterine cancer	9.29e-05	0.000165	CcSEcCtD
Cevimeline—Vomiting—Epirubicin—uterine cancer	9.02e-05	0.000161	CcSEcCtD
Cevimeline—Diarrhoea—Doxorubicin—uterine cancer	8.98e-05	0.00016	CcSEcCtD
Cevimeline—Rash—Epirubicin—uterine cancer	8.95e-05	0.000159	CcSEcCtD
Cevimeline—Dermatitis—Epirubicin—uterine cancer	8.94e-05	0.000159	CcSEcCtD
Cevimeline—Headache—Epirubicin—uterine cancer	8.89e-05	0.000158	CcSEcCtD
Cevimeline—Dizziness—Doxorubicin—uterine cancer	8.68e-05	0.000154	CcSEcCtD
Cevimeline—Nausea—Epirubicin—uterine cancer	8.43e-05	0.00015	CcSEcCtD
Cevimeline—Vomiting—Doxorubicin—uterine cancer	8.35e-05	0.000149	CcSEcCtD
Cevimeline—Rash—Doxorubicin—uterine cancer	8.28e-05	0.000147	CcSEcCtD
Cevimeline—Dermatitis—Doxorubicin—uterine cancer	8.27e-05	0.000147	CcSEcCtD
Cevimeline—Headache—Doxorubicin—uterine cancer	8.23e-05	0.000146	CcSEcCtD
Cevimeline—Nausea—Doxorubicin—uterine cancer	7.8e-05	0.000139	CcSEcCtD
